Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3Infertility 2Infertility, Female 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × follitropin beta × Clear all
NCT03197077 2023-04-07

Elonva_IVM

Universitair Ziekenhuis Brussel

Phase 3 Completed
145 enrolled

Infertility, Female, Polycystic Ovary Syndrome

NCT01081639 2014-07-31

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
34 enrolled

Infertility, Polycystic Ovary Syndrome

NCT00805935 2012-01-27

Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

Ferring Pharmaceuticals

Phase 4 Completed
110 enrolled 22 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡